Epidemiologic Data of Patients in a Teaching Hospital

This study has been completed.
Sponsor:
Information provided by:
Luzerner Kantonsspital
ClinicalTrials.gov Identifier:
NCT00114335
First received: June 14, 2005
Last updated: October 9, 2008
Last verified: October 2008
  Purpose

This small cross-sectional epidemiological study is designed to evaluate the prevalence of the following parameters in hospitalized patients in a tertiary teaching hospital (medical department only):

  • kidney insufficiency
  • obesity
  • use of unfractionated heparins / low molecular weight heparins
  • other drugs effecting the hemostatic system

Condition
Kidney Diseases
Obesity

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Prevalence of Impaired Renal Function in Medical Inpatients

Resource links provided by NLM:


Further study details as provided by Luzerner Kantonsspital:

Enrollment: 352
Study Start Date: May 2005
Study Completion Date: July 2005
Detailed Description:

This small cross-sectional epidemiological study is designed to evaluate the prevalence of the following parameters in hospitalized patients in a tertiary teaching hospital (medical department only):

  • kidney insufficiency
  • obesity
  • use of unfractionated heparins / low molecular weight heparins
  • other drugs effecting the hemostatic system
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All patients hospitalized at the defined days (two days) at Kantonsspital Luzern, Department of Medicine

Criteria

Inclusion Criteria:

  • All patients hospitalized at the defined days (two days) at Kantonsspital Luzern, Department of Medicine
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00114335

Locations
Switzerland
Kantonsspital Luzern
Luzern, LU, Switzerland, 6000
Sponsors and Collaborators
Luzerner Kantonsspital
Investigators
Principal Investigator: P Schmid, MD Kantonsspital Luzern, Hematology
Study Director: A G Fischer, MD Kantonsspital Luzern, Nephrology
Study Chair: W A Wuillemin, MD, PhD Kantonsspital Luzern, Hematology
  More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00114335     History of Changes
Other Study ID Numbers: LMWHplus_1
Study First Received: June 14, 2005
Last Updated: October 9, 2008
Health Authority: Switzerland: Swissmedic

Keywords provided by Luzerner Kantonsspital:
low molecular weight heparin
unfractionated heparin

Additional relevant MeSH terms:
Kidney Diseases
Obesity
Urologic Diseases
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms
Heparin, Low-Molecular-Weight
Anticoagulants
Hematologic Agents
Therapeutic Uses
Pharmacologic Actions
Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Cardiovascular Agents

ClinicalTrials.gov processed this record on July 20, 2014